DECEMBER 5, 2017
Chesapeake Regional Healthcare will Implement Glytec’s Software to Bolster High-Reliability Care
Glytec’s eGlycemic Management System® will ensure clinicians have ready access to evidence-based decision support for personalized insulin therapy management.
Waltham, MA — Fostering a culture of patient safety is integral to the care Chesapeake Regional Healthcare delivers, and a new partnership with Glytec will enable best practices in glycemic management across all inpatient service lines. Glytec’s eGlycemic Management System® will support the optimization of intravenous and subcutaneous insulin therapy during hospitalization, and will provide evidence-based guidance on transitions in insulin therapy from hospital to home.
“Keeping patients’ blood glucose within the normal range is vital to their safety and recovery,” says Dr. Raymond McCue, Vice President of Medical Affairs and Chief Medical Officer at Chesapeake Regional Healthcare. “As a high-reliability organization, we strive to standardize care and reduce variation throughout our organization, and adopting advanced technologies like Glytec’s helps us achieve those goals.”
Insulin therapy during hospitalization is quite common, either because of diabetes or a condition known as stress-induced hyperglycemia, wherein blood glucose becomes elevated due to the stress of acute illness or treatment received. Glytec’s software-as-a-medical-device provides clinical care teams with evidence-based decision support to ensure that insulin therapy is managed safely and effectively, according to best practices established by the American Diabetes Association and American Association of Clinical Endocrinologists.
“By personalizing insulin therapy and simplifying the processes that surround insulin dosing, Glytec’s software will play an important role in our overarching tenet of zero patients harmed,” McCue adds. “It will also aid us in fully adopting basal bolus insulin methodologies, which are proven superior to sliding scale.”
Glytec’s clinical services team will work hand in hand with clinicians and staff of Chesapeake Regional Healthcare to overcome impediments that have long challenged the sustained utilization of basal bolus insulin methodologies. Glytec’s team will also help facilitate a comprehensive plan for continuous improvement in glycemic management, including surveillance, protocols, order sets, workflows and education programs as well as ongoing governance, measurement, analytics, response mechanisms and more.
“Chesapeake Regional Healthcare views excellence in service to our patients as a priority above all else,” says McCue, “and we look forward to incorporating Glytec’s innovative tools and processes to reach new heights in patient satisfaction and outcomes.”
Glytec’s President & CEO, Bob Leonard, adds: “We are very pleased to welcome Chesapeake Regional Healthcare to our customer family, and look forward to a highly collaborative working relationship. We applaud the spirit and commitment they demonstrate toward adopting best practices in glycemic management for their entire inpatient population.”
Founded in 2006, Glytec is the pioneer of personalized digital therapeutics. The company’s patented and FDA-cleared software-as-a-medical-device solutions improve the safety and health of people with diabetes and make insulin a more effective and accessible medication option for millions who are unable to achieve their treatment goals. Glytec combines evidence-based decision support technologies with expert clinical services to optimize basal and bolus insulin therapies in the hospital and at home, and in turn reduce hypoglycemia and other complications as well as avoidable ED visits, hospitalizations, readmissions and drug waste. The company has offices in Waltham, Massachusetts and Greenville, South Carolina. For more information visit www.glytecsystems.com.
About Chesapeake Regional Healthcare
Chesapeake Regional Healthcare is home to Chesapeake Regional Medical Center, the only independent, community-based hospital in the Hampton Roads region providing technologically advanced health care to the residents of southeastern Virginia and northeastern North Carolina. It offers a nationally accredited Chest Pain Center, a Bariatric Surgery Center of Excellence, four Women’s Choice Awards and one of the busiest Emergency Departments and maternity wards in the area. With more than 600 physicians and the first da Vinci® XI Surgical System in the state of Virginia, Chesapeake Regional is dedicated to putting patients first with the most advanced treatments in health care and a personalized touch. Website: www.chesapeakeregional.com.